Figure 5.

Hazard curve for HCV/HIV co-infected and HIV mono-infected patients, stratified by HCV co-infection status, CD4+ cell count and HAART use.

Taye and Lakew BMC Immunology 2013 14:23   doi:10.1186/1471-2172-14-23
Download authors' original image